EIPR – Product-by-process claims: clarification form the UK court in Hospira v Genetech

[{“id”:”ed308lwb93xt2″,”elType”:”container”,”settings”:{“flex_direction”:”column”},”elements”:[{“id”:”5820cba”,”elType”:”container”,”settings”:[],”elements”:[{“id”:”_ed308lwb93xz5″,”elType”:”widget”,”settings”:{“editor”:”EIPR Vol 37, Issue 5 (E.I.P.R. 2015, 37(5), 314-320)

The recent decision in Hospira v Genetch addresses the rules concerning novelty of product-by-process claims, and how different sorts of ‘by-process’ language limit the scope of the claim of the purposes of considering infringement. The judgment provides helpful guidance on the construction and validity of product-by-process claims under UK law.

Penny Gilbert and Sam Carter review the judgment in the recent issue of European Intellectual Property Review.“,”drop_cap”:”no”,”typography_typography”:”custom”,”typography_letter_spacing”:{“unit”:”px”,”size”:”0″},”typography_font_size”:{“unit”:”px”,”size”:”18″},”size”:”18″,”typography_font_weight”:”400″,”typography_line_height”:{“unit”:”px”,”size”:”28″},”title_color”:”#4b2771″,”text_color”:”#4b2771″,”color”:”#4b2771″,”align”:”start”},”widgetType”:”text-editor”}],”isInner”:false}],”isInner”:false}]